
|

| |
Track the *RXDIA Index |
 |
|
 | Diabetes Stocks (*RXDIA) |
| |
Diabetes Ideas |
|
|
|
Diabetes Performance |
|
|
|
Diabetes Community |
|
| |
|
Index Description: These medical firms have significant exposure to treatments and therapies for diabetes
|
|
|
|
|
Today:
1-month:
All-time:
|
-2.1%
+15.3%
-25.8%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
-2.2%
+9.6%
-23.8%
|
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
|
$7.5B
4.5
0.1%
|
|
|
|
|
Share this Index on Facebook
Share this Index on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
| |
|
| |

Click
a column to sort | Scroll over columns for more information |
|
|
| AMLN |
$17.05 |
+0.58 |
+3.5% |
5,449,196 |
120% |
$2.4B |
- |
112% |
-7% |
1 Alert (0 News) - View
|
|
|
| ARRY |
$2.60 |
-0.59 |
-18.5% |
8,187,288 |
1824% |
$201.8M |
- |
65% |
-24% |
3 Alerts (1 News) - View
|
|
|
| BIOD |
$0.66 |
+0.02 |
+3.0% |
1,348,381 |
605% |
$23.5M |
- |
30% |
-75% |
1 Alert (1 News) - View
|
|
|
| DEPO |
$6.53 |
-0.40 |
-5.8% |
739,125 |
126% |
$383.3M |
- |
55% |
-36% |
No Alerts/News
|
|
|
| DMED |
$0.77 |
0.00 |
0.0% |
1,402 |
5% |
$6.1M |
- |
8% |
-89% |
No Alerts/News
|
|
|
| DXCM |
$11.37 |
0.00 |
0.0% |
251,276 |
47% |
$790.4M |
- |
68% |
-33% |
No Alerts/News
|
|
|
| GNBT |
$0.16 |
-0.01 |
-4.4% |
1,066,504 |
43% |
$51.2M |
- |
113% |
-50% |
No Alerts/News
|
|
|
| MNKD |
$2.41 |
+0.01 |
+0.4% |
1,411,196 |
58% |
$319.1M |
- |
13% |
-54% |
1 Alert (0 News) - View
|
|
|
| NVO |
$135.02 |
-0.19 |
-0.1% |
239,060 |
74% |
$78.0B |
1.3% |
43% |
-0% |
No Alerts/News
|
|
|
| PODD |
$19.88 |
+0.74 |
+3.9% |
405,949 |
108% |
$927.8M |
- |
42% |
-15% |
1 Alert (1 News) - View
|
|
|
| SPEX |
$1.05 |
-0.01 |
-0.9% |
23,503 |
16% |
$2.6M |
- |
11% |
-82% |
No Alerts/News
|
|
|
|
Is this index incomplete or incorrect?
Got an idea for a new Index?
|
|
|
| |

|
| |
|
| |

|
| |
Insulet Reports Fourth Quarter and Full Year 2011 Results PODD
Linked by marketwire ( track newsfeed | ignore newsfeed ) - February 09, 04:15PM from (www2.marketwire.com) Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod(R) Insulin Management
Flag
Post a comment
Mid-day Movers IPSU ARRY AONE DMND TSL
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - February 09, 12:24PM from (247wallst.wordpress.com) At about noon, the three major equity indexes have all turned positive after an up-and-down morning. The DJIA is up about
Flag
Post a comment
American Apparel, Micron, MetLife, TiVo: U.S. Equity Preview MU DEPO BWLD TIVO MET APP ZGNX
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - February 05, 12:32PM from (www.bloomberg.com) Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses.
Flag
Post a comment
24/7 Wall St. Closing Bell PKI MRO WY BEAM NVLS GILD ZOLT CHK MNKD URBN PEET EL PCCC RIMM THLD GNW STRI TUDO
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - February 03, 04:09PM from (247wallst.com) Major indexes reacted positively to this morning’s non-farm payrolls report and the drop in the US unemployment rate from
Flag
Post a comment
Mid-day Movers MNKD THLD MNOV OPTT ZNGA
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - February 03, 12:09PM from (247wallst.com) Among the major movers at around noon today are Threshold Pharmaceuticals Inc. (NASDAQ: THLD), Ocean Power Technologies Inc.
Flag
Post a comment
Amylin Pharmaceuticals Continues to Soar in Wake of Bydureon Approval LLY ALKS AMLN GS JEF DB
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - February 02, 01:49PM from (www.benzinga.com) Last Friday, the FDA finally approved Bydureon, a once-weekly diabetes shot developed by Amylin Pharmaceuticals (NASDAQ:
Flag
Post a comment
Life Sciences Development Rebounds in Central New Jersey BMY JNJ NVO JLL CSGP
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - January 31, 09:17PM from (feeds.nytimes.com) With its concentration of pharmaceutical giants and academic powerhouses, the region could be a major center for life sciences
Flag
Post a comment
Mid-day Movers GCI PBY TNB AMLN GTXI
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - January 30, 11:45AM from (247wallst.com) Among the major movers at around noon today are Thomas & Betts Corp. (NYSE: TNB), Pep Boys - Manny, Joe & Jack (NYSE: PBY),
Flag
Post a comment
Alkermes, Amylin, Delta Air, US Airways: U.S. Equity Preview DAL LCC ALKS AMLN
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - January 27, 06:02PM from (www.bloomberg.com) Shares of the following companies may have unusual moves in U.S. trading on Jan. 30. Stock symbols are in parentheses, and prices are as of 5 p.m. in New York.
Flag
Post a comment
Bydureon, a Diabetes Drug from Amylin, Wins F.D.A. Approval LLY NVO ALKS AMLN
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - January 27, 05:34PM from (feeds.nytimes.com) The Food and Drug Administration twice declined to approve Bydureon in 2010, with its most serious concern being that the
Flag
Post a comment
D. Medical Signs Fifth U.S. Distribution Agreement for Spring Universal Infusion Sets DMED
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - January 25, 08:00AM from (www.globenewswire.com) TIRAT CARMEL, Israel, Jan. 25, 2012 (GLOBE NEWSWIRE) -- D. Medical Industries Ltd. (Nasdaq:DMED) (TASE:DMED) ("D. Medical"
Flag
Post a comment
Depomed Announces Initiation of Phase 2 Clinical Study in Parkinson's Disease DEPO
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - January 24, 04:05PM from (www.globenewswire.com) MENLO PARK, Calif., Jan. 24, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that it has initiated a
Flag
Post a comment
Depomed Receives Notice of Paragraph IV Certification Against Patents for Gralise(TM) DEPO
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - January 23, 04:30PM from (www.globenewswire.com) MENLO PARK, Calif., Jan. 23, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that it has received a
Flag
Post a comment
|
|
|